A systematic review of p53 regulation of oxidative stress in skeletal muscle

References

• Drake JC, Wilson RJ, Yan Z. Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J 2016;30(1):13–22. doi: 10.1096/fj.15-276337
   PubMed Web of Science ®Google Scholar
• Carter HN, Chen CWC, Hood DA. Mitochondria, muscle health, and exercise with advancing age. Physiology. 2015;30(3):208–223. doi: 10.1152/physiol.00039.2014
   PubMed Web of Science ®Google Scholar
• Ljubicic V, Joseph AM, Adhihetty PJet al. Molecular basis for an attenuated mitochondrial adaptive plasticity in aged skeletal muscle. Aging. 2009;1(9): 818–830. doi: 10.18632/aging.100083
   PubMedGoogle Scholar
• Warburton DE, Charlesworth S, Ivey A, et al. A systematic review of the evidence for Canada's physical activity guidelines for adults. Int J Behav Nutr Phys Act. 2010;7: 39. doi: 10.1186/1479-5868-7-39
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1): 44–84. doi: 10.1016/j.biocel.2006.07.001
   PubMed Web of Science ®Google Scholar
• Liu B, Chen Y, St. Clair DK. Ros and p53: a versatile partnership. Free Radical Bio Med. 2008;44(8):1529–1535. doi: 10.1016/j.freeradbiomed.2008.01.011
   PubMed Web of Science ®Google Scholar
• Hybertson BM, Gao B, Bose SK, et al. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32(4–6):234–246. doi: 10.1016/j.mam.2011.10.006
   PubMed Web of Science ®Google Scholar
• Schieber M, Chandel NS. Ros functions in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–R462. doi: 10.1016/j.cub.2014.03.034
   PubMed Web of Science ®Google Scholar
• Holley AK, Clair DK S. Watching the watcher: regulation of p53 by mitochondria. Future Oncol. 2009;5(1):117–130. doi: 10.2217/14796694.5.1.117
   PubMed Web of Science ®Google Scholar
• Levine AJ, Feng Z, Mak TW, et al. Coordination and communication between the p53 and IGF-1-AKT-mTOR signal transduction pathways. Genes Dev. 2006;20:267–75. doi: 10.1101/gad.1363206
   PubMed Web of Science ®Google Scholar
• Saleem A, Adhihetty PJ, Hood DA. Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol Genomics. 2009;37(1):58–66. doi: 10.1152/physiolgenomics.90346.2008
   PubMed Web of Science ®Google Scholar
• Saleem A, Carter HN, Hood DA. P53 is necessary for the adaptive changes in cellular milieu subsequent to an acute bout of endurance exercise. Am J Physiol Cell Physiol. 2014;306(3):C241–C249. doi: 10.1152/ajpcell.00270.2013
   PubMed Web of Science ®Google Scholar
• Smeenk L, van Heeringen SJ, Koeppel M, et al. Characterization of genome-wide p53 binding sites upon stress response. Nucleic Acids Res. 2008;36(11):3639–3654. doi: 10.1093/nar/gkn232
   PubMed Web of Science ®Google Scholar
• Rotblat B, Melino G, Knight RA. Nrf2 and p53: januses in cancer? Oncotarget. 2012;3(11):1272–1283. doi: 10.18632/oncotarget.754
   PubMed Web of Science ®Google Scholar
• Liu D, Xu Y. P53, oxidative stress, and aging. Antioxid Redox Signal 2011;15(6):1669–1678. doi: 10.1089/ars.2010.3644
   PubMed Web of Science ®Google Scholar
• Marino G, Niso-Santano M, Baehrecke EH, et al. Self-consumption: the interplay of autophagy and apoptosis. Nature Rev. 2014;15:81–94. doi: 10.1038/nrm3735
   Web of Science ®Google Scholar
• Ljubicic V, Joseph AM, Saleem A, et al. Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging. Biochim Biophys Acta. 2010;1800(3):223–234. doi: 10.1016/j.bbagen.2009.07.031
   PubMed Web of Science ®Google Scholar
• Qi Z, He J, Zhang Y, et al. Exercise training attenuates oxidative stress and decreases p53 protein content in skeletal muscle of type 2 diabetic goto-kakizaki rats. Free Radic Biol Med. 2011;50(7):794–800. doi: 10.1016/j.freeradbiomed.2010.12.022
   PubMed Web of Science ®Google Scholar
• Steinbacker P, Eckl P. Impact of oxidative stress on exercising skeletal muscle. Biomolecules. 2015;5(2):356–377. doi: 10.3390/biom5020356
   PubMed Web of Science ®Google Scholar
• Li X, Fang P, Mai J, et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013;6:19. doi: 10.1186/1756-8722-6-19
   PubMed Web of Science ®Google Scholar
• Chen YW, Nader GA, Baar KR, et al. Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol. 2002;545:27–41. doi: 10.1113/jphysiol.2002.021220
   PubMed Web of Science ®Google Scholar
• Saleem A, Carter HN, Iqbal S, et al. Role of p53 within the regulatory network controlling muscle mitochondrial biogenesis. Exerc Sport Sci Rev. 2011;39(4):199–205.
   PubMed Web of Science ®Google Scholar
• Matoba S, Kang JG, Patino WD, et al. P53 regulates mitochondrial respiration. Science. 2006;312(5780):1650–1653. doi: 10.1126/science.1126863
   PubMed Web of Science ®Google Scholar
• Saleem A, Hood DA. Acute exercise induces tumour suppressor protein p53 translocation to the mitochondria and promotes a p53-tfam-mitochondrial DNA complex in skeletal muscle. J Physiol. 2013;591(14):3625–3636. doi: 10.1113/jphysiol.2013.252791
   PubMed Web of Science ®Google Scholar
• Donahue RJ, Razmara M, Hoek JB, et al. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. FASEB J 2001;15:635–644. doi: 10.1096/fj.00-0262com
   PubMed Web of Science ®Google Scholar
• Park JY, Wang PY, Matsumoto T, et al. P53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res. 2009;105(7):705–712. doi: 10.1161/CIRCRESAHA.109.205310
   PubMed Web of Science ®Google Scholar
• Granata C, Oliveira RS, Little JP, et al. Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle. Sci Rep. 2017;7:44227. doi: 10.1038/srep44227
   PubMed Web of Science ®Google Scholar
• Tachtsis B, Smiles WJ, Lane SC, et al. Acute endurance exercise induced nuclear p53 abundance in human skeletal muscle. Front Physiol. 2016;7:144. doi: 10.3389/fphys.2016.00144
   PubMed Web of Science ®Google Scholar
• Achanta G, Sasaki R, Feng L, et al. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J 2005;24:3482–3492. doi: 10.1038/sj.emboj.7600819
   PubMed Web of Science ®Google Scholar
• Bakhanashvili M, Grinberg S, Bonda E, et al. Excision of nucleoside analogs in mitochondria by p53 protein. AIDS. 2009;23:779–788. doi: 10.1097/QAD.0b013e328329c74e
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Izumi H, Torigoe T, et al. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 2003;63:3729–3734.
   PubMed Web of Science ®Google Scholar
• Safdar A, Khrapko K, Flynn JM, et al. Exercise-induced mitochondrialp53 repairs mtDNA mutations in mutator mice. Skelet Muscle. 2016;6:7. doi: 10.1186/s13395-016-0075-9
   PubMed Web of Science ®Google Scholar
• Siu PM, Always SE. Subcellular responses of p53 and Id2 in fast and slow skeletal muscle in response to stretch-induced overload. J Appl Physiol (1985). 2005;99(5):1897–1904. doi: 10.1152/japplphysiol.00374.2005
   PubMed Web of Science ®Google Scholar
• Granata C, Oliveira RS, Little JP, et al. Mitochondria adaptations to high-volume exercise training are rapidly reversed after a reduction in training volume in human skeletal muscle. FASEB J 2016;30(10):3413–3423. doi: 10.1096/fj.201500100R
   PubMed Web of Science ®Google Scholar
• Bartlett JD, Hwa Joo C, Jeong TS, et al. Matched work high-intensity interval and continuous running induce similar increases in PGC-1α mRNA, AMPK, p38, and p53 phosphorylation in human skeletal muscle. J Appl Physiol (1985). 2012;112(7):1135–43. doi: 10.1152/japplphysiol.01040.2011
   PubMed Web of Science ®Google Scholar
• Puzio-Kuter AM. The role of p53 in metabolic regulation. Genes Cancer. 2011;2(4):385–391. doi: 10.1177/1947601911409738
   PubMedGoogle Scholar
• Heiden MG V, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033. doi: 10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Schupp M, Chen F, Briggs ER, et al. Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues. BMC Genomics. 2013;14:758. doi: 10.1186/1471-2164-14-758
   PubMed Web of Science ®Google Scholar
• Canto C, Auwerx J. Calorie restriction: is AMPK a key sensor and effector? Physiology. 2011;14:214–224. doi: 10.1152/physiol.00010.2011
   Google Scholar
• Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;14:7–13. doi: 10.1093/ajcn/86.1.7
   Google Scholar
• Bartlett JD, Louhelainen J, Iqbal Z, et al. Reduced carbohydrate availability enhances exercise-induced p53 signaling in human skeletal muscle: implications for mitochondrial biogenesis. Am J Physiol Regul Integr Comp Physiol. 2013;30(46):R450–R458. doi: 10.1152/ajpregu.00498.2012
   Google Scholar
• Bartlett JD, Close GL, Drust B, et al. The emerging role of p53 in exercise metabolism. Sports Med. 2014;44(3):303–9. doi: 10.1007/s40279-013-0127-9
   PubMed Web of Science ®Google Scholar
• Camera DM, Hawley JA, Coffey VG. Resistance exercise with low glycogen increases p53 phosphorylation and PGC-1α mRNA in skeletal muscle. Eur J Appl Physiol. 2015;115(6):1185–94. doi: 10.1007/s00421-015-3116-x
   PubMed Web of Science ®Google Scholar
• Edwards MG, Anderson RM, Yuan M, et al. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics. 2007;8:80. doi: 10.1186/1471-2164-8-80
   PubMed Web of Science ®Google Scholar
• Cahill GF, Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;14: 1–22. doi: 10.1146/annurev.nutr.26.061505.111258
   Google Scholar
• Zechner R, Zimmermann R, Eichmann TO, et al. Fat signals–lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012;14:279–291. doi: 10.1016/j.cmet.2011.12.018
   Google Scholar
• Aquilano K, Baldelli S, Cardaci S, et al. Nitric oxide is the primary mediator of cytotoxicity induced by GSH depletion in neuronal cells. J Cell Sci. 2011;124:1043–1054. doi: 10.1242/jcs.077149
   PubMed Web of Science ®Google Scholar
• Aquilano K, Baldelli S, Pagliei B, et al. P53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid Redox Signal. 2013;18(4):386–399. doi: 10.1089/ars.2012.4615
   PubMed Web of Science ®Google Scholar
• Assaily W, Rubinger DA, Wheaton K, et al. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Mol Cell. 2011;44(3):491–501. doi: 10.1016/j.molcel.2011.08.038
   PubMed Web of Science ®Google Scholar
• Finck BN, Gropler MC, Chen Z, et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 2006;4:199–210. doi: 10.1016/j.cmet.2006.08.005
   PubMed Web of Science ®Google Scholar
• Bensaad K, Cheung EC, Vousden KH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009;28:3015–3026. doi: 10.1038/emboj.2009.242
   PubMed Web of Science ®Google Scholar
• Bensaad K, Tsuruta A, Selak MA, et al. Tigar, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006;126:107–120. doi: 10.1016/j.cell.2006.05.036
   PubMed Web of Science ®Google Scholar
• Hu W, Zhang C, Wu R, et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA. 2010;106(16):7455–7460. doi: 10.1073/pnas.1001006107
   Google Scholar
• Espinosa-Diez C, Miguel V, Mennerich D, et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 2015;6:183–197. doi: 10.1016/j.redox.2015.07.008
   PubMed Web of Science ®Google Scholar
• Holloszy JO, Booth FW. Biochemical adaptations to endurance exercise in muscle. . Annu Rev Physiol. 1976;38:273–291. doi: 10.1146/annurev.ph.38.030176.001421
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Okada S, Nakagomi A, et al. Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity. Cell Rep. 2014;7(5):1691–1703. doi: 10.1016/j.celrep.2014.04.046
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA. 2009;96:4240–4245. doi: 10.1073/pnas.96.8.4240
   Google Scholar
• Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000;20:1868–1876. doi: 10.1128/MCB.20.5.1868-1876.2000
   PubMed Web of Science ®Google Scholar
• Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004;64:2627–2633. doi: 10.1158/0008-5472.CAN-03-0846
   PubMed Web of Science ®Google Scholar
• Russell SJ, Kahn CR. Endocrine regulation of ageing. Nat Rev Mol Cell Biol. 2007;8:681–691. doi: 10.1038/nrm2234
   PubMed Web of Science ®Google Scholar
• Luo X, Wu J, Jing S, et al. Hyperglycemic stress and carbon stress in diabetic glucotoxicity. Aging Dis. 2016;7(1):90–110. doi: 10.14336/AD.2015.0702
   PubMed Web of Science ®Google Scholar
• Nakahara T, Hashimoto K, Hirano M, et al. Acute and chronic effects of alcohol exposure on skeletal muscle c-myc, p53, and Bcl-2 mRNA expression. Am J Physiol Endocrinol Metab. 2003;285(6):E1273–E1281. doi: 10.1152/ajpendo.00019.2003
   PubMed Web of Science ®Google Scholar
• Preedy VR, Adachi J, Ueno Y, et al. Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis. Eur J Neurol. 2001;8:677–687. doi: 10.1046/j.1468-1331.2001.00303.x
   PubMed Web of Science ®Google Scholar
• Reilly ME, McKoy G, Mantle D, et al. Protein and mRNA levels of the myosin heavy chain isoforms I, IIa, IIx and IIb in type I and type II fibre predominant rat skeletal muscles in response to chronic alcohol feeding. J Muscle Res Cell Motil. 2000;21:763–773. doi: 10.1023/A:1010336624154
   PubMed Web of Science ®Google Scholar
• Taira T, Negishi Y, Kihara F, et al. c-myc protein complex binds to two sites in human hsp70 promoter region. Biochim Biophys Acta. 1992;1130:166–174. doi: 10.1016/0167-4781(92)90524-4
   PubMedGoogle Scholar
• Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031–1044. doi: 10.1016/S1097-2765(02)00520-8
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Bando YK, Shigeta T, et al. Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53. J Atherscler Thromb. 2011;18(3):200–208. doi: 10.5551/jat.6437
   PubMed Web of Science ®Google Scholar
• Schwarzkopf M, Coletti D, Sassoon D, et al. Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev 2006;20:3440–3452. doi: 10.1101/gad.412606
   PubMed Web of Science ®Google Scholar
• Fox DK, Ebert SM, Bongers KS, et al. Atf4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. Am J Physiol Endocrinol Metab. 2014;307:E245–E261. doi: 10.1152/ajpendo.00010.2014
   PubMed Web of Science ®Google Scholar
• White JD, Collins R, Vermuelen R, et al. The role of p53 in vivo during skeletal muscle post-natal development and regeneration: studies in p53 knockout mice. Int J Dev Biol. 2002;46:577–582.
   PubMed Web of Science ®Google Scholar
• Nakazawa H, Chang K, Shinozaki S, et al. Inos as a driver of inflammation and apoptosis in mouse skeletal muscle after burn injury: possible involvement of Sirt1 s-nitrosylation mediated acetylation of p65 NF-kB and p53. PLOS ONE. 2017;12(1):1–18. doi: 10.1371/journal.pone.0170391
   Web of Science ®Google Scholar
• Wang X, Hu Z, Hu J, et al. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. J Endocrin. 2006;147(9):4160–4168. doi: 10.1210/en.2006-0251
   Google Scholar
• Shinozaki S, Chang K, Sakai M, et al. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal. 2015;7(351):ra106. doi: 10.1126/scisignal.2005375
   Web of Science ®Google Scholar
• Desplanches D, Mayet MH, Sempore B, et al. Structural and functional responses to prolonged hindlimb suspension in rat muscle. J Appl Physiol. 1987;63:558–563. doi: 10.1152/jappl.1987.63.2.558
   PubMed Web of Science ®Google Scholar
• Siu PM, Pistilli EE, Murlasits Z, et al. Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 protein in young adult and aged rats. J Appl Physiol (1985). 2006;100(3):907–916. doi: 10.1152/japplphysiol.01012.2005
   PubMed Web of Science ®Google Scholar
• Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51:1884–1888. doi: 10.2337/diabetes.51.6.1884
   PubMed Web of Science ®Google Scholar
• Szalay K, Razga Z, Duda E. Tnf inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur J Cell Biol. 1997;74:391–398.
   PubMed Web of Science ®Google Scholar
• Gomes MD, Lecker SH, Jagoe RT, et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci. 2001;98:14440–14445. doi: 10.1073/pnas.251541198
   PubMed Web of Science ®Google Scholar
• Tazi EM, Errihani H. Treatment of cachexia in oncology. Indian J Palliat Care. 2010;16(3):129–137. doi: 10.4103/0973-1075.73644
   PubMedGoogle Scholar
• Wang C, Liu W, Liu Z, et al. Hypoxia inhibits myogenic differentiation through p53 protein-dependent induction of Bhlhe40 protein. J Biol Chem. 2015;290(50):29707–29716. doi: 10.1074/jbc.M115.688671
   PubMed Web of Science ®Google Scholar
• Yun Z, Lin Q, Giaccia AJ. Adaptive myogenesis under hypoxia. Mol Cell Biol. 2005;25:3040–3055. doi: 10.1128/MCB.25.8.3040-3055.2005
   PubMed Web of Science ®Google Scholar
• Hoppeler H, Vogt M. Muscle tissue adaptations to hypoxia. J Exp Biol. 2001;204:3133–3139.
   PubMed Web of Science ®Google Scholar
• Greenbaum AR, Etherington PJ, Manek S, et al. Measurements of oxygenation and perfusion in skeletal muscle using multiple microelectrodes. J Muscle Res Cell Motil. 1997;18:149–159. doi: 10.1023/A:1018653521686
   PubMed Web of Science ®Google Scholar
• Zhang J, Biggar KK, Storey KB. Regulation of p53 by reversible post-transcriptional and post-transcriptional mechanisms in liver and skeletal muscle of an anorexia tolerant turtle, trachemys scripta elegans. Gene. 2013;513:147–155. doi: 10.1016/j.gene.2012.10.049
   PubMed Web of Science ®Google Scholar
• Carlo A D, Mori R D, Martelli F, et al. Hypoxia inhibits myogenic differentiation through accelerated myod degradation. J Biol Chem. 2004;279:16332–16338. doi: 10.1074/jbc.M313931200
   PubMed Web of Science ®Google Scholar
• Gustafsson MV, Zheng X, Pereira T, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005;9:617–628. doi: 10.1016/j.devcel.2005.09.010
   PubMed Web of Science ®Google Scholar
• Buas MF, Kabak S, Kadesch T. Inhibition of myogenesis by notch: evidence for multiple pathways. J Cell Physiol. 2009;218(1):84–93. doi: 10.1002/jcp.21571
   PubMed Web of Science ®Google Scholar
• Liu W, Wen Y, Bi P, et al. Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development. 2012;139:2857–2865. doi: 10.1242/dev.079665
   PubMed Web of Science ®Google Scholar
• Majmundar AJ, Skuli N, Mesquita RC, et al. O-2 regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling. Mol Cell Biol. 2012;32:36–49. doi: 10.1128/MCB.05857-11
   PubMed Web of Science ®Google Scholar
• Little JB. Principal cellular and tissue effects of radiation. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei cancer medicine. 6th edition. Hamilton (ON): BC Decker; 2003.
   Google Scholar
• Little JB, Nagasawa H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat Res. 1985;101:81–93. doi: 10.2307/3576305
   PubMed Web of Science ®Google Scholar
• Yang ZJP, Kenzelmann Broz D, Noderer WL, et al. P53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress. Cell Death Differ.. 2015;22:560–573. doi: 10.1038/cdd.2014.189
   PubMed Web of Science ®Google Scholar
• Lin T, Chao C, Saito S, et al. P53 induces differentiation of mouse embryonic stem cells by suppressing nanog expression. Nat Cell Biol. 2015;7:165–171. doi: 10.1038/ncb1211
   Google Scholar
• Schwarzkopf M, Coletti D, Marazzi G, et al. Chronic p53 activity leads to skeletal muscle atrophy and muscle stem cell perturbation. Basic Appl Myol. 2009;18:131–138.
   Google Scholar
• Feng Z, Hu W, de Stanchina E, et al. The regulation of AMPK β1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007;67(7): 3043–3053. doi: 10.1158/0008-5472.CAN-06-4149
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang H, Levine AJ, et al. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA. 2005;102:8204–8209. doi: 10.1073/pnas.0502857102
   PubMed Web of Science ®Google Scholar
• Levine AJ, Hu W, Feng Z. The p53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13:1027–1036. doi: 10.1038/sj.cdd.4401910
   PubMed Web of Science ®Google Scholar
• Jones RG, Plas DR, Kubek S, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18:283–293. doi: 10.1016/j.molcel.2005.03.027
   PubMed Web of Science ®Google Scholar
• Pronsato L, Milanesi L. Effect of testosterone on the regulation of p53 and p66Shc during oxidative stress damage in C2C12 cells. Steroids. 2016;106:41–54. doi: 10.1016/j.steroids.2015.12.007
   PubMed Web of Science ®Google Scholar
• Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;22:221–233. doi: 10.1016/j.cell.2005.05.011
   Google Scholar
• Le S, Connors TJ, Maroney AC. C-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem. 2001;276:48332–48336. doi: 10.1074/jbc.M106612200
   PubMed Web of Science ®Google Scholar
• Natalicchio A, De Stefano F, Perrini S, et al. Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts. Am J Physiol Endocrinol Metab. 2009;296:E228–E237. doi: 10.1152/ajpendo.90347.2008
   PubMed Web of Science ®Google Scholar
• Natalicchio A, Tortosa F, Perrini S, et al. p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress. Arch Physiol Biochem. 2011;117:116–124. doi: 10.3109/13813455.2011.562513
   PubMedGoogle Scholar
• Colla A L, Vasconsuelo A, Milanesi L, et al. 17β-Estradiol protects skeletal myoblasts from apoptosis through p53, Bcl-2, and FoxO families. J Cell Biochem. 2017;118:104–115. doi: 10.1002/jcb.25616
   PubMed Web of Science ®Google Scholar
• Hori YS, Kuno A, Hosoda R, et al. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLOS ONE. 2013;8(9):e73875. doi: 10.1371/journal.pone.0073875
   PubMed Web of Science ®Google Scholar
• Essers MA, Weijzen S, de Vries-Smits AM, et al. Foxo transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004;23:4802–4812. doi: 10.1038/sj.emboj.7600476
   PubMed Web of Science ®Google Scholar
• Attardi LD, Reczek EE, Cosmas C, et al. Perp, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 2000;14(6):704–18.
   PubMed Web of Science ®Google Scholar
• Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2011;288:1053–1058. doi: 10.1126/science.288.5468.1053
   Google Scholar
• Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120:2479–2487. doi: 10.1242/jcs.001222
   PubMed Web of Science ®Google Scholar
• Roux I L, Konge J, Le Cam L, et al. Numb is required to prevent p53-dependent senescence following skeletal muscle injury. Nat Commun. 2015;6:8528. doi: 10.1038/ncomms9528
   PubMed Web of Science ®Google Scholar
• Xu Y, Li N, Xiang R, et al. Emerging roles of the p38 MAPK and PI3 K /AKT /mTOR pathways in oncogene-induced stress. Trends Biochem Sci. 2014;39(6):268–276. doi: 10.1016/j.tibs.2014.04.004
   PubMed Web of Science ®Google Scholar
• Liu S, Li J, Tao Y, et al. Small heat shock protein αB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Bioph Res Co. 2007;354:109–114. doi: 10.1016/j.bbrc.2006.12.152
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4:793–805. doi: 10.1038/nrc1455
   PubMed Web of Science ®Google Scholar
• Fiordaliso F, Leri A, Cesselli D, et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 2001;50(10):2363–75. doi: 10.2337/diabetes.50.10.2363
   PubMed Web of Science ®Google Scholar
• Ogawara Y, Kishishita S, Obata T, et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 2002;277:21843–21850. doi: 10.1074/jbc.M109745200
   PubMed Web of Science ®Google Scholar
• Baldelli S, Ciriolo MR. Altered S-nitrosylation of p53 is responsible for impaired antioxidant response in skeletal muscle during aging. Aging. 2016;8(12): 3450–3462. doi: 10.18632/aging.101139
   PubMedGoogle Scholar
• Irrcher I, Ljubicic V, Kirwan AF, et al. Amp activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLOS One. 2008;3:e3614. doi: 10.1371/journal.pone.0003614
   PubMed Web of Science ®Google Scholar
• Relaix F, Wei XJ, Wu X. Peg3/Pw1is an imprinted gene involved in the TNF–NFKB signal transduction pathway. Nat Genet. 1998;18:287–291. doi: 10.1038/ng0398-287
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Loss of skeletal muscle in cancer: biochemical mechanisms. Front Biosci. 2001;6:D164–D174.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Gardner SE, Clarke MC. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2011;31:2781–2786. doi: 10.1161/ATVBAHA.111.224907
   PubMed Web of Science ®Google Scholar
• Di Y, Aminot Y, Schroeder DC, et al. Integrated biological responses and tissue-specific expression of p53 and ras genes in marine mussels following exposure to benzo(a)pyrene and C60 fullerenes, either alone or in combination. Mutagenesis. 2017;32:77–90. doi: 10.1093/mutage/gew049
   PubMed Web of Science ®Google Scholar
• Kamat JP, Devasagayam TP, Priyadarsini KI, et al. Oxidative damage induced by the fullerene C60 on photosensitization in rat liver microsomes. Chem Biol Interact. 1998;114: 145–159. doi: 10.1016/S0009-2797(98)00047-7
   PubMed Web of Science ®Google Scholar
• Saada YB, Zakharova V, Chernyak B, et al. Control of DNA integrity in skeletal muscle under physiological and pathological conditions. Cell Mol Life Sci. 2017;4(19):3439–3449. doi: 10.1007/s00018-017-2530-0
   Google Scholar
• Alfadda AA, Sallam RM. Reactive oxygen species in health and disease. J Biomed Biotech. 2012;2012:936486. doi: 10.1155/2012/936486
   PubMedGoogle Scholar